Increasing serum complement component 1q is associated with worse prognosis in advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a single-center, retrospective study

Jiazhuo Tang, Yang Fu, Yuxiao Song, Jiaxin Yin, Jun Wang, Hugo Arasanz, Bicheng Zhang